Upregulation of Striatal Dopamine-2 Receptors in Brattleboro Rats with Prepulse Inhibition Deficits

Biological Psychiatry

Volumn 60, Issue 11, 2006, Pages 1278-1281

  Shilling, Paul D ^a   Kinkead, Becky ^b   Murray, Tiesha ^b   Melendez, Gilia ^a   Nemeroff, Charles B ^b   Feifel, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Brattleboro rat; caudate putamen; dopamine receptor; nucleus accumbens; schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SCHIZOPHRENIA; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, RADIATION; NEURAL INHIBITION; RATS; RATS, BRATTLEBORO; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STARTLE REACTION; UP-REGULATION;

EID: 33750629797     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.045     Document Type: Article

References (30)

1. Boer G.J. Vasopressin and brain development: Studies using the Brattleboro rat. Peptides 6 suppl 1 (1985) 49-62
2. Bohus B., and De Wied D. The vasopressin deficient Brattleboro rats: A natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res 119 (1998) 555-573
3. Chambers R.A., Krystal J.H., and Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50 (2001) 71-83
4. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology. 7th edition. (1996), Oxford University Press, New York
5. Cornish J.L., Wilks D.P., and Van den Buuse M. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats. Neuroscience 81 (1997) 69-78
6. Elman I., Lukas S., Shoaf S.E., Rott D., Adler C., and Breier A. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. J Psychopharmacol 17 (2003) 317-323
7. Feifel D., Melendez G., and Shilling P.D. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: A potential predictive model for novel antipsychotic effects. Neuropsychopharmacology 29 (2004) 731-738
8. Feifel D., and Priebe K. Vasopressin deficient rats exhibit prepulse inhibition deficits that are reversed by subchronic haloperidol. Biol Psychiatry 50 (2001) 425-433
9. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology (Berl) 156 (2001) 117-154
10. Goto Y., and O'Donnell P. Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. J Neurosci 22 (2002) 9070-9077
11. Hirvonen J., van Erp T.G., Huttunen J., Aalto S., Nagren K., Huttunen M., et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 62 (2005) 371-378
12. Joyce J.N., Goldsmith S.G., and Gurevich E.V. Limbic circuits and monoamine receptors: Dissecting the effects of antipsychotics from disease processes. J Psychiatr Res 31 (1997) 197-217
13. Kestler L.P., Walker E., and Vega E.M. Dopamine receptors in the brains of schizophrenia patients: A meta-analysis of the findings. Behav Pharmacol 12 (2001) 355-371
14. Kishimoto T., Hirai M., Ohsawa H., Terada M., Matsuoka I., and Ikawa G. Manners of arginine vasopressin secretion in schizophrenic patients-with reference to the mechanism of water intoxication. Jpn J Psychiatry Neurol 43 (1989) 161-169
15. Knable M.B., Egan M.F., Heinz A., Gorey J., Lee K.S., Coppola R., and Weinberger D.R. Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study. Br J Psychiatry 171 (1997) 574-577
16. Kodsi M.H., and Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci 109 (1995) 912-928
17. Kodsi M.H., and Swerdlow N.R. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res 773 (1997) 45-52
18. Kovacs G.L., Szabo G., Szontagh L., Medve L., Telegdy G., and Laszlo F.A. Hereditary diabetes insipidus in rats. Altered cerebral indolamine and catecholamine metabolism. Neuroendocrinology 31 (1980) 189-193
19. Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 42 (1998) 211-221
20. Legros J.J., Gazzotti C., Carvelli T., Franchimont P., Timsit-Berthier M., von Frenckell R., and Ansseau M. Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology. 17 (1992) 611-617
21. O'Donnell P., and Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 24 (1998) 267-283
22. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, New York
23. Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7 (1992) 261-284
24. Segal D.S., and Schuckit M.A. Animal models of stimulant-induced psychosis. In: Creese I. (Ed). Stimulants: Neurochemical, Behavioral, and Clinical Perspectives (1983), Raven Press, New York 131-167
25. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., and Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl) 100 (1990) 413-416
26. van Heuven-Nolsen D., de Kloet E.R., De Wied D., and Versteeg D.H. Microinjection of vasopressin and two related peptides into the amygdala: Enhancing effect on local dopamine neurotransmission. Brain Res 293 (1984) 191-195
27. van Heuven-Nolsen D., and Versteeg D.H. Interaction of vasopressin with the nigro-striatal dopamine system: site and mechanism of action. Brain Res 337 (1985) 269-276
28. Wan F.J., Geyer M.A., and Swerdlow N.R. Accumbens D2 modulation of sensorimotor gating in rats: Assessing anatomical localization. Pharmacol Biochem Behav 49 (1994) 155-163
29. Wan F.J., and Swerdlow N.R. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 722 (1996) 168-176
30. Zakzanis K.K., and Hansen K.T. Dopamine D2 densities and the schizophrenic brain. Schizophr Res 32 (1998) 201-206